IBM closed at $212.67 on the 17th at the New York Stock Exchange, down 2.91% from the previous session and approximately 36% below its 52-week high of $332.46 recorded last month on the 2nd. The stock declined over 25% after the company released preliminary Q2 results on the 14th, showing revenue of $17.2 billion (versus estimates of $17.86 billion, a ~3.7% miss) and Non-GAAP EPS of $2.93 (versus estimates of $3.03, a ~3% miss). Market concerns centered on software growth deceleration, as analysts estimate IBM's organic growth excluding M&A effects fell to 0-1%. The decline reflects investor worries that AI infrastructure investments are shifting IT budgets from software to hardware, delaying multi-year software contract signings as customers prioritize memory, servers, and storage procurement.
IBM Reports Preliminary Q2 Revenue and EPS Below Estimates
IBM disclosed preliminary Q2 results on the 14th with revenue of $17.2 billion, approximately 3.7% below the estimated $17.86 billion. Non-GAAP earnings per share came in at $2.93, missing the $3.03 estimate by roughly 3%. Following the announcement, IBM stocks dropped more than 25%. The preliminary figures indicated organic growth of 0-1% when excluding merger and acquisition contributions, according to analyst estimates.
Analysts Attribute Stock Decline to Software Growth Concerns
Park Ki-hyun, a Kiwoom Securities analyst, stated the market reacted not to the earnings miss itself but to the erosion of IBM's premium valuation as a "double-digit growth software company." The software business slowdown is interpreted as a signal of IT budget reallocation, with customers prioritizing hardware acquisitions—memory, servers, and storage—over software contract renewals. Park noted that IBM's software division relies heavily on multi-year large contracts, and signing timelines have been pushed back as clients secure hardware infrastructure first. He added that interpreting this as a collapse in software demand would be premature, suggesting the preliminary results reflect temporary shifts in customer investment priorities rather than diminished demand.
IBM Scheduled to Release Full Earnings Report on the 22nd
IBM will publish its regular earnings report on the 22nd. Park identified three key factors for investors to monitor: whether IBM maintains its annual Free Cash Flow guidance of $15 billion, whether delayed large contracts are executed in Q3, and demand trends across the software industry as reflected in Microsoft and other peers' earnings reports during the season. He stated that until these three elements are confirmed, the recent sharp decline should be understood as the market pricing in a worst-case scenario.
FAQ
What caused IBM stocks to fall approximately 36% from their recent high?
IBM stocks fell to $212.67 on the 17th, approximately 36% below the 52-week high of $332.46 recorded last month on the 2nd. The decline followed preliminary Q2 results released on the 14th showing revenue of $17.2 billion (versus estimates of $17.86 billion) and Non-GAAP EPS of $2.93 (versus estimates of $3.03), with the stock dropping over 25% immediately after the announcement.
Why did analysts express concern about IBM's software business growth?
Analysts estimate IBM's organic growth excluding M&A effects fell to 0-1% in Q2. Market concerns focus on software growth deceleration as customers prioritize hardware investments—memory, servers, and storage—over multi-year software contract renewals, delaying IBM's large contract signings in the software division.
What will investors monitor in IBM's earnings report on the 22nd?
Investors will focus on three factors: whether IBM maintains its annual Free Cash Flow guidance of $15 billion, whether delayed large contracts are executed in Q3, and demand trends across the software industry as indicated by Microsoft and other peers' earnings reports during the season.
